Physician profile
Suzanne D Devine
NPI 1942209085
$4,694.22
in general payments reported to CMS, 2019-2025
7 companies · $148 in 2025
The $148 reported for 2025 was more than what 83% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $533 · 2023: $1,183 · 2024: $2,709 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,367 · Travel and Lodging: $1,655 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,367.38 |
| Travel and Lodging | $1,654.76 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $3,150.20 | 2022-2024 | Xeomin |
| Intuitive Surgical, INC. | $879.53 | 2023 | Da Vinci Surgical System |
| Galderma Laboratories, L.P. | $360.96 | 2022-2024 | |
| Noah Medical Corporation | $132.01 | 2025 | Galaxy |
| Pacira Pharmaceuticals Incorporated | $121.23 | 2021 | |
| Merck Sharp & Dohme LLC | $34.63 | 2024 | Bridion |
| Solventum Corporation | $15.66 | 2025 | Bair Paws |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.